乳房植入物筛查指南在乳腺癌重建中的评估
该研究回顾性分析2012至2017年单术者376例植入物乳房重建患者,硅胶植入物占87%,20%在术后5-6年内接受常规MRI筛查,植入物破裂26例(7%),硅胶植入物破裂中59%经MRI筛查诊断,38%无症状经筛查发现,作者指出筛查依从性低。
要点
- 376例植入物乳房重建中,破裂26例(7%),平均破裂时间5.9±4.0年。
- 硅胶植入物破裂59%经MRI筛查诊断,38%无症状经筛查发现。
- 术后5-6年内接受常规MRI筛查者仅75例(20%)。
核心结论
- 硅胶植入物乳房重建中MRI筛查破裂检出率为59%,患者依从性相对较低(术后5-6年内20%),凸显筛查挑战,应告知患者植入物破裂风险及一生中可能需要更换的可能性。
研究设计与样本
- 回顾性综述,纳入2012至2017年单术者植入物乳房重建的乳腺癌患者,要求至少5年随访,共376例,盐水植入物13%、硅胶植入物87%。
主要发现
- 376例中75例(20%)在术后5-6年内接受常规MRI筛查,植入物破裂26例(7%),平均植入至破裂时间5.9±4.0年。
- 硅胶植入物破裂中59%经MRI筛查诊断,38%无临床症状经常规MRI筛查发现;盐水植入物破裂均出现临床症状。
- 影像学上破裂分类为囊内破裂81%、囊外破裂12%;73%的破裂在植入物更换术中经手术确认;破裂诊断至植入物取出/更换的中位时间为3个月(范围0.5-21个月)。
关键数值与推荐
- 2020年美国食品药品监督管理局更新乳房植入物破裂监测建议:硅胶植入物置入后5-6年行超声筛查或磁共振成像(MRI),此后每2-3年重复筛查。
临床怎么用
- 作者认为应告知患者植入物破裂风险及一生中可能需要更换植入物的可能性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In 2020, the US Food and Drug Administration updated its surveillance recommendations for breast implant rupture to ultrasound screening or magnetic resonance imaging (MRI) 5-6 years following silicone implant placement, with repeat screening every 2-3 years thereafter. This study evaluates the risk of implant rupture and assesses the utility of routine surveillance MRIs in diagnosing implant rupture. METHODS: We performed a retrospective review of patients with implant-based reconstruction for breast cancer with a single surgeon between 2012 and 2017. Inclusion criteria included a 5-year minimum follow-up period. Analysis was performed to elucidate rupture rate and associated factors. RESULTS: A total of 376 patients underwent reconstruction with saline (13%) and silicone implants (87%). Seventy-five (20%) underwent routine MRI screening within 5-6 years of surgery. Implant rupture occurred in 26 patients (7%). Average time from implant placement to rupture was 5.9 ± 4.0 years. Fifty-nine percent of silicone implant ruptures were diagnosed by MRI screening. Thirty-eight percent of silicone implant ruptures presented without clinical symptoms and were identified on routine MRI screening. All saline implant ruptures presented with clinical symptoms. On imaging, ruptures were classified as intracapsular (81%) or extracapsular (12%). Seventy-three percent of ruptures were confirmed intraoperatively during implant replacement. Median time for rupture diagnosis to implant removal/replacement was 3 months (range, 0.5-21 months). CONCLUSIONS: MRI screening for silicone implant rupture in implant-based breast reconstruction had a 59% detection rate, with relatively low patient adherence (20% within 5-6 years after surgery), highlighting the challenges of screening. Patients should be counseled on the risk of implant rupture and the likelihood of needing replacement during their lifetime.
引用
- Mehta M, Zhang C, Sarrami S, et al. Evaluating Breast Implant Screening Guidelines in Breast Cancer Reconstruction. Ann Plast Surg. 2025. PMID: 40167067. doi:10.1097/SAP.0000000000004329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。